Cargando…

RNA Interference for the Treatment of Papillomavirus Disease

Human Papillomavirus (HPV)-induced diseases are a significant burden on our healthcare system and current therapies are not curative. Vaccination provides significant prophylactic protection but effective therapeutic treatments will still be required. RNA interference (RNAi) has great promise in pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singhania, Richa, Khairuddin, Norliana, Clarke, Daniel, McMillan, Nigel AJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547394/ https://www.ncbi.nlm.nih.gov/pubmed/23341856 http://dx.doi.org/10.2174/1874357901206010204

Ejemplares similares

Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA
por: McCaskill, Jana, et al.
Publicado: (2013)

Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal Administration
por: Singhania, Akul, et al.
Publicado: (2011)

Development of novel lipidic particles for siRNA delivery that are highly effective after 12 months storage
por: Clarke, Daniel, et al.
Publicado: (2019)

Hyperactivating p53 in Human Papillomavirus-Driven Cancers: A Potential Therapeutic Intervention
por: Idres, Yusuf M., et al.
Publicado: (2022)

Potent Inhibition of Hendra Virus Infection via RNA Interference and Poly I:C Immune Activation
por: McCaskill, Jana L., et al.
Publicado: (2013)

Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription
por: Endo-Munoz, Liliana, et al.
Publicado: (2005)

Review: An urgent need for research on factors impacting adherence to and retention in care among HIV-positive youth and adolescents from key populations
por: Lall, Priya, et al.
Publicado: (2015)

The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System
por: Jubair, Luqman, et al.
Publicado: (2017)

Prevalence and types of high-risk human papillomaviruses in head and neck cancers from Bangladesh
por: Shaikh, Mushfiq H., et al.
Publicado: (2017)

siRNA Mediate RNA Interference Concordant with Early On-Target Transient Transcriptional Interference
por: Fang, Zhiming, et al.
Publicado: (2021)

A review of protocols for brain organoids and applications for disease modeling
por: Mayhew, Christopher N., et al.
Publicado: (2022)

Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection
por: Supramaniam, Aroon, et al.
Publicado: (2023)

Two-photon interference between disparate sources for quantum networking
por: McMillan, A. R., et al.
Publicado: (2013)

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
por: Idris, Adi, et al.
Publicado: (2021)

E-scooter-related facial injuries: a one-year review following implementation of a citywide trial
por: Sritharan, Rajeevan, et al.
Publicado: (2023)

Rearrangements of integral membrane components during in vitro aging of sheep erythrocyte membranes
por: Lutz, HU, et al.
Publicado: (1977)

Early Satiety — An Unusual Cause
por: Weir, Robin AP, et al.
Publicado: (2006)

RNA Interference
por: Sioud, Mouldy, et al.
Publicado: (2006)

Development of an intravaginal ring for the topical delivery of Aurora kinase A inhibitor, MLN8237
por: Tayyar, Yaman, et al.
Publicado: (2019)

Targeting Viral Heart Disease by RNA Interference
por: Merl, S., et al.
Publicado: (2008)

A fungal Argonaute interferes with RNA interference
por: Nguyen, Quyet, et al.
Publicado: (2018)

A fungal Argonaute interferes with RNA interference
por: Nguyen, Quyet, et al.
Publicado: (2018)

RNA Interference Technology
por: Xu, Wei, et al.
Publicado: (2019)

Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature
por: Sav, Adem, et al.
Publicado: (2017)

RNA Interference in Practice
por: Lau, Alan
Publicado: (2005)

Liposomal Delivery of miR-34b-5p Induced Cancer Cell Death in Thyroid Carcinoma
por: Maroof, Hamidreza, et al.
Publicado: (2018)

Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease
por: Chambers, George, et al.
Publicado: (2014)

Advances with RNA interference in Alzheimer’s disease research
por: Chen, Shun, et al.
Publicado: (2013)

RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?
por: Unniyampurath, Unnikrishnan, et al.
Publicado: (2016)

Combination of RNA Interference and Stem Cells for Treatment of Central Nervous System Diseases
por: Hou, Xue-Qin, et al.
Publicado: (2017)

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics
por: Swerdlow, Daniel I, et al.
Publicado: (2021)

RNA Interference in Ticks
por: Kocan, Katherine M., et al.
Publicado: (2011)

RNA interference in practice /
por: Schepers, Ute
Publicado: (2005)

Respiratory viral diseases: access to RNA interference therapy
por: Bitko, Vira, et al.
Publicado: (2007)

Interfering with disease: opportunities and roadblocks to harnessing RNA interference
por: Lieberman, Judy, et al.
Publicado: (2003)

RNA interference approaches for treatment of HIV-1 infection
por: Bobbin, Maggie L, et al.
Publicado: (2015)

RNA interference in glial cells for nerve injury treatment
por: Lin, Junquan, et al.
Publicado: (2020)

Spectrum of Darkness, Agent of Light: Myopia, Keratoconus, Ocular Surface Disease, and Evidence for a Profoundly Vitamin D-dependent Eye
por: McMillan, James
Publicado: (2018)

Current prospects for RNA interference-based therapies
por: Davidson, Beverly L., et al.
Publicado: (2011)

RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders: Status and Challenges
por: Poller, W., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0k8d98ecqtb9kd2gh6ui9b3j07